SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-074317
Filing Date
2021-05-28
Accepted
2021-05-28 17:16:09
Documents
12
Period of Report
2021-05-27
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2117999d1_8k.htm   iXBRL 8-K 32053
  Complete submission text file 0001104659-21-074317.txt   210419

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptgx-20210527.xsd EX-101.SCH 3208
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptgx-20210527_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptgx-20210527_pre.xml EX-101.PRE 22725
5 EXTRACTED XBRL INSTANCE DOCUMENT tm2117999d1_8k_htm.xml XML 3858
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37852 | Film No.: 21981636
SIC: 2834 Pharmaceutical Preparations